Table 3.
Clinical potential of miRNAs/lncRNAs in DLBCL.
| miRNA/ncRNA | Putative Role | Clinical Potential | References |
|---|---|---|---|
| hsa-miR-155 | OncomiR | Prognostic biomarker | [155,156] |
| hsa-miR-221/222 | OncomiR | Prognostic biomarker | [129] |
| hsa-miR-146a | OncomiR | Prognostic biomarker | [156] |
| hsa-miR-146b | OncomiR | Prognostic biomarker | [157] |
| hsa-miR-18a | OncomiR | Prognostic biomarker | [158] |
| hsa-miR-21 | OncomiR | Prognostic biomarker | [159] |
| hsa-miR-181a | OncomiR | Prognostic biomarker | [129,160] |
| hsa-miR-222 | OncomiR | Prognostic biomarker | [129] |
| 19-lncRNA | Oncogene | Prognostic biomarker | [123] |
| 17-lncRNA | Oncogene | Diagnostic and prognostic biomarker | [144] |
| 6-lncRNA | Oncogene | Prognostic biomarker | [146] |
| NAALADL2-AS2 | Oncogene | Diagnostic biomarker | [141] |
| NON-HSAT120161 | Oncogene | Diagnostic biomarker | [141] |
| PEG10 | Oncogene | Prognostic biomarker | [154] |
| HOTAIR | Oncogene | Prognostic biomarker | [149] |
| NEAT1 | Oncogene | Prognostic biomarker | [150] |
| NONHSAG026900 | Tumor suppressor | Prognostic biomarker | [151] |